President Trump unveiled a wide-ranging executive order that aims to lower drug prices, boost transparency into fees charged ...

Brain health has emerged as one of the defining challenges of our time, driven by a double whammy of soaring rates of ...

Biogen Pharmachem Industries Ltd share price ... Canara Banks; check details Thank you! Your transaction has been completed successfully. Sorry! Transaction failed. Please try again later.

Thank you. You may begin. Thank you ... has been interesting, right, following Biogen and then now with successes from Eisai and Lilly. And given our ability to clearly measure what are meaningful ...

“Biogen has been a foundational presence in the Massachusetts life science ecosystem for close to half a century,” said Governor Maura Healey, in a statement. “We are thrilled to see them ...

Biogen's $7.22 per share buyout offer signals confidence in Sage's commercial potential and drug pipeline. Read why SAGE ...

Shares of Biogen Inc. BIIB shed 1.44% to $115.29 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...

Shares of Biogen Inc. BIIB slipped 5.90% to $113.38 Thursday, on what proved to be an all-around rough trading session for ...

Biogen's research organization recently went through an overhaul that company leaders say should allow the Cambridge drugmaker to increase the number of molecules that get into the clinic, and then, ...